GLP-1 drugs can be a helpful tool, but theyre not magic
Vendors who explicitly market retatrutide for human use, weight loss, or personal health benefits are operating outside the research chemical framework and exposing both themselves and their customers to regulatory risk
Most patients weigh factors like the molecule and brand, what theyre being treated for, their insurance situation, and how their body responds to a particular treatment
[DOI] [PubMed] [Google Scholar] 195.Siddiqui N., Ali J., Parvez S., Najmi A.K., Akhtar M
If people are hesitant about participating, they might feel hesitant about even taking the drug since they dont know how it was tested, and risk not getting the advantage of the drug. Fostering relationships between research teams and diverse populations is the first step toward incorporating underrepresented communities in the clinical trial process